Title | Type 2 Diabetes Modifies the Association of CAD Genomic Risk Variants With Subclinical Atherosclerosis. |
Publication Type | Journal Article |
Year of Publication | 2023 |
Authors | Hasbani, NR, Westerman, KE, Kwak, SHeon, Chen, H, Li, X, Di Corpo, D, Wessel, J, Bis, JC, Sarnowski, C, Wu, P, Bielak, LF, Guo, X, Heard-Costa, N, Kinney, GL, Mahaney, MC, Montasser, ME, Palmer, ND, Raffield, LM, Terry, JG, Yanek, LR, Bon, J, Bowden, DW, Brody, JA, Duggirala, R, Jacobs, DR, Kalyani, RR, Lange, LA, Mitchell, BD, Smith, JA, Taylor, KD, Carson, AP, Curran, JE, Fornage, M, Freedman, BI, Gabriel, S, Gibbs, RA, Gupta, N, Kardia, SLR, Kral, BG, Momin, Z, Newman, AB, Post, WS, Viaud-Martinez, KA, Young, KA, Becker, LC, Bertoni, AG, Blangero, J, Carr, JJ, Pratte, K, Psaty, BM, Rich, SS, Wu, JC, Malhotra, R, Peyser, PA, Morrison, AC, Vasan, RS, Lin, X, Rotter, JI, Meigs, JB, Manning, AK, de Vries, PS |
Corporate Authors | NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium; TOPMed Atherosclerosis Working Group; TOPMed Diabetes Working Group |
Journal | Circ Genom Precis Med |
Volume | 16 |
Issue | 6 |
Pagination | e004176 |
Date Published | 2023 Dec |
ISSN | 2574-8300 |
Keywords | Atherosclerosis, Carotid Intima-Media Thickness, Coronary Artery Disease, Diabetes Mellitus, Type 2, Genomics, Humans, Plaque, Atherosclerotic, Risk Factors |
Abstract | BACKGROUND: Individuals with type 2 diabetes (T2D) have an increased risk of coronary artery disease (CAD), but questions remain about the underlying pathology. Identifying which CAD loci are modified by T2D in the development of subclinical atherosclerosis (coronary artery calcification [CAC], carotid intima-media thickness, or carotid plaque) may improve our understanding of the mechanisms leading to the increased CAD in T2D. METHODS: We compared the common and rare variant associations of known CAD loci from the literature on CAC, carotid intima-media thickness, and carotid plaque in up to 29 670 participants, including up to 24 157 normoglycemic controls and 5513 T2D cases leveraging whole-genome sequencing data from the Trans-Omics for Precision Medicine program. We included first-order T2D interaction terms in each model to determine whether CAD loci were modified by T2D. The genetic main and interaction effects were assessed using a joint test to determine whether a CAD variant, or gene-based rare variant set, was associated with the respective subclinical atherosclerosis measures and then further determined whether these loci had a significant interaction test. RESULTS: Using a Bonferroni-corrected significance threshold of CONCLUSIONS: These results highlight T2D as an important modifier of rare variant associations in CAD loci with CAC. |
DOI | 10.1161/CIRCGEN.123.004176 |
Alternate Journal | Circ Genom Precis Med |
PubMed ID | 38014529 |
PubMed Central ID | PMC10843644 |
Grant List | R01 HL113323 / HL / NHLBI NIH HHS / United States R01 HL120393 / HL / NHLBI NIH HHS / United States K01 DK133637 / DK / NIDDK NIH HHS / United States R01 HL139553 / HL / NHLBI NIH HHS / United States K99 AG066849 / AG / NIA NIH HHS / United States U01 HL120393 / HL / NHLBI NIH HHS / United States R01 HL105756 / HL / NHLBI NIH HHS / United States R01 HL159514 / HL / NHLBI NIH HHS / United States R01 HL146860 / HL / NHLBI NIH HHS / United States P01 HL045522 / HL / NHLBI NIH HHS / United States R01 HL145025 / HL / NHLBI NIH HHS / United States U54 HG013247 / HG / NHGRI NIH HHS / United States R01 HL117626 / HL / NHLBI NIH HHS / United States R01 HL142809 / HL / NHLBI NIH HHS / United States R00 AG066849 / AG / NIA NIH HHS / United States R01 DK127636 / DK / NIDDK NIH HHS / United States R01 HL151855 / HL / NHLBI NIH HHS / United States UM1 DK078616 / DK / NIDDK NIH HHS / United States |
Type 2 Diabetes Modifies the Association of CAD Genomic Risk Variants With Subclinical Atherosclerosis.
Similar Publications
DNA Methylation-Derived Immune Cell Proportions and Cancer Risk in Black Participants. Cancer Res Commun. 2024;4(10):2714-2723. | .
StratoMod: predicting sequencing and variant calling errors with interpretable machine learning. Commun Biol. 2024;7(1):1316. | .
Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk. BMC Med Genomics. 2024;17(1):255. | .